Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites

The characteristics of the binding of [3H]paroxetine, a selective serotonin (5-HT) uptake blocker, were investigated in human brain. The Kd value was 0.23 +/- 0.07 nM, and the Bmax value was 190 +/- 39 fmol/mg protein in the putamen. The capacity of various antidepressive drugs to inhibit [3H]paroxetine-specific binding in human brain was well correlated with their capacity to inhibit [3H]5-HT uptake in rat brain. The highest concentrations of [3H]paroxetine-specific binding sites were found in the substantia nigra, hypothalamus, and hippocampus. Lower values were obtained in the basal ganglia and the thalamus. The specific binding was very low in cerebral and cerebellar cortices. The regional distribution of [3H]paroxetine binding sites differs from that of [3H]ketanserin binding to S2 serotonin receptors. The subcellular distribution of the [3H]paroxetine-specific binding sites obtained by differential centrifugation revealed a synaptosomal enrichment in the frontal cortex and striatum, whereas an enrichment in the microsomal fraction was found in striatum. The results show that [3H]paroxetine is a ligand of choice to label the 5-HT uptake molecular complex in human brain.

[1]  P. Laduron,et al.  [3H]Desipramine and [3H]imipramine binding are not associated with noradrenaline and serotonin uptake in the brain. , 1982, European journal of pharmacology.

[2]  P. Plenge,et al.  High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes. , 1983, European journal of pharmacology.

[3]  S. Z. Langer,et al.  Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes. , 1986, European journal of pharmacology.

[4]  J. B. Lassen.  Potent and long-lasting potentiation of two 5-hydroxytryptophan- induced effects in mice by three selective 5-ht uptake inhibitors. , 1978, European journal of pharmacology.

[5]  Y. Agid,et al.  High and low affinity [3H]imipramine binding sites in control and parkinsonian brains. , 1985, European journal of pharmacology.

[6]  J. Maloteaux,et al.  Different Subcellular Localization of Muscarinic and Serotonin (S2) Receptors in Human, Dog, and Rat Brain , 1986, Journal of neurochemistry.

[7]  L. Wennogle,et al.  Human brain receptor alterations in suicide victims , 1982, Pharmacology Biochemistry and Behavior.

[8]  H. Schoemaker,et al.  Temperature Dependence of Drug Interaction with the Platelet 5‐Hydroxytryptamine Transporter: A Clue to the Imipramine Selectivity Paradox , 1987, Journal of neurochemistry.

[9]  F. Goodwin,et al.  Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. , 1980, Life sciences.

[10]  Y. Agid,et al.  [3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons. , 1983, European journal of pharmacology.

[11]  R. Wattiaux,et al.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. , 1955, The Biochemical journal.

[12]  E. Perry,et al.  Decreased Imipramine Binding in the Brains of Patients with Depressive Illness , 1983, British Journal of Psychiatry.

[13]  Y. Agid,et al.  Parkinson's disease: decreased density of 3H-imipramine and 3H- paroxetine binding sites in putamen , 1986, Neurology.

[14]  A. Schoutens,et al.  Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects , 1986, Biological Psychiatry.

[15]  S. Gershon,et al.  Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. , 1982, Science.

[16]  J. Hyttel,et al.  Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  J. Glowinski,et al.  Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds , 1964, Nature.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[19]  J. Maloteaux,et al.  Characterization and regional distribution of serotonin S2-receptors in human brain , 1983, Brain Research.

[20]  P. Davies,et al.  REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN , 1978, Journal of neurochemistry.

[21]  A. Lajtha,et al.  High‐ and Low‐Affinity Binding of [3H]Imipramine in Mouse Cerebral Cortex , 1983, Journal of neurochemistry.

[22]  M. Briley,et al.  Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding. , 1980, European journal of pharmacology.

[23]  Y. Claustre,et al.  Characterization of [3H]paroxetine binding to rat cortical membranes. , 1985, European journal of pharmacology.

[24]  J. Maloteaux.  Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors. , 1986, Acta neurologica Belgica.

[25]  K. Fuxe,et al.  The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. , 1971, Neuropharmacology.

[26]  Y. Agid,et al.  Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain , 1981, Journal of neurochemistry.

[27]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[28]  C. Braestrup,et al.  Multiple benzodiazepine receptors , 1980, Trends in Neurosciences.

[29]  P. Hrdina.  Differentiation of two components of specific [3H]imipramine binding in rat brain. , 1984, European journal of pharmacology.

[30]  P. Laduron.  Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts. , 1977, International review of neurobiology.

[31]  E. Perry,et al.  Postmortem Neurochemical Studies in Depression , 1986, Annals of the New York Academy of Sciences.